Komori
Sumitomo Osaka Cement (5232) · InitiativeAdvanced

Strengthening research and development based on proprietary technologies

First written in FY2016. 25 of 33 entries say "Restated". Latest entry: FY2026.

33entries
11years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2020-Q3RestatedFY2023-Q2 – FY2024-Q32016: 320162017: 320172018: 320182019: 320192020: 420202021: 420212022: 420222023: 320232024: 320242025: 220252026: 12026
Same theme, other companies
Strengthening New Product and Technology Development Capabilities Through R&D and Basic ResearchA theme 216 companies write about · 0 as a headwind · 228 as a tailwind

115 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 228 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026AdvancedAnnual report

    「R&D expenses for the fiscal year were ¥3,559 million, and the objectives, major issues, research results and R&D expenses for each segment are as follows.」

    The Company invested ¥3,559 million in R&D and advanced commercialization of LN modulators for 1.2Tbps and 1.6Tbps applications, elemental technologies for next-generation optical devices and commercialization of electrostatic chucks for next-generation semiconductor equipment.
  2. FY2026-H1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the interim consolidated accounting period was ¥1,821 million. There were no significant changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    The Company continued its R&D activities and disclosed interim R&D expenses of ¥1,821 million. It stated that there were no significant changes in the status of its R&D activities.
  3. FY2025AdvancedAnnual report

    「R&D expenses for the fiscal year were ¥3,552 million, and the objectives, major issues, research results and R&D expenses for each segment are as follows. …① Commercialization of coherent LN modulators adapted to 800Gbps/1.2Tbps transmission systems ② Development of elemental technologies for coherent LN modulators adapted to 1.6Tbps transmission systems ③ Development of elemental technologies for next-generation compact optical devices」

    The Company invested ¥3,552 million in R&D and reported full-year results including commercialization of modulators for 800Gbps and 1.2Tbps applications and development of technologies for 1.6Tbps applications.
  4. FY2025-H1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the interim consolidated accounting period was ¥1,800 million. There were no significant changes in the status of the Group's R&D activities during the interim consolidated accounting period.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥1,800 million for the interim consolidated accounting period. It stated that there were no significant changes in the status of its R&D activities.
  5. FY2024AdvancedAnnual report

    「R&D expenses for the fiscal year were ¥3,523 million, and the objectives, major issues, research results and R&D expenses for each segment are as follows.」

    R&D expenses were ¥3,523 million. In optoelectronics, the Company advanced commercialization of modulators for 800Gbps and 1.2Tbps applications and development of elemental technologies for 1.6Tbps applications. In new materials, it advanced commercialization and elemental technology development for electrostatic chucks for next-generation semiconductor equipment.
  6. FY2024-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,631 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company disclosed cumulative third-quarter R&D expenses of ¥2,631 million and reconfirmed that there were no significant changes in the status of its R&D activities.
  7. FY2024-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,747 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The Company disclosed R&D expenses of ¥1,747 million and reconfirmed that there were no significant changes in the status of its R&D activities.
  8. FY2024-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥892 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company disclosed R&D expenses of ¥892 million and reconfirmed that there were no significant changes in the status of its R&D activities.
  9. FY2023-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,193 million. The main results for the fiscal year were as follows: ① Development and performance enhancement of repair materials for concrete floor slabs ② Performance enhancement of sectional repair materials and surface-coating materials ③ Development of labor-saving construction methods ④ Development of environmentally friendly materials. R&D activities in the lithium iron phosphate battery materials business were terminated in connection with the transfer of that business.」

    The Company continued its R&D activities and disclosed cumulative third-quarter R&D expenses of ¥2,193 million and results in the construction materials field. It also reconfirmed that R&D activities in the battery materials field ended in connection with the transfer of that business.
  10. FY2023-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,447 million.」

    The Company continued its R&D activities and disclosed R&D expenses of ¥1,447 million for the cumulative second quarter.
  11. FY2023-Q1ReframedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥719 million. The main results for the fiscal year were as follows: ① Development and performance enhancement of repair materials for concrete floor slabs ② Performance enhancement of sectional repair materials and surface-coating materials ③ Development of labor-saving construction methods ④ Development of environmentally friendly materials. R&D activities in the lithium iron phosphate battery materials business were terminated in connection with the transfer of that business.」

    While R&D continues in fields such as construction materials, R&D activities in the battery materials field ended in connection with the transfer of the battery materials business, changing the scope of activities.
  12. FY2022AdvancedAnnual report

    「R&D expenses for the fiscal year were ¥3,052 million, and the objectives, major issues, research results and R&D expenses for each segment are as follows. …① Development of coherent LN modulators adapted to 800Gbps transmission systems ② Development of elemental technologies for next-generation compact optical devices」

    The Company invested ¥3,052 million in R&D and identified specific development themes, including optical modulators for 800Gbps applications and elemental technologies for next-generation compact optical devices.
  13. FY2022-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,261 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company disclosed R&D expenses of ¥2,261 million and reconfirmed that there were no significant changes in its R&D activities.
  14. FY2022-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,513 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed first-half R&D expenses of ¥1,513 million.
  15. FY2022-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥729 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company disclosed R&D expenses of ¥729 million and reconfirmed that there were no significant changes in its R&D activities.
  16. FY2021AdvancedAnnual report

    「R&D expenses for the fiscal year were ¥3,184 million, and the objectives, major issues, research results and R&D expenses for each segment are as follows.」

    The Company invested ¥3,184 million in R&D and advanced specific product and elemental technology development projects in multiple fields, including optical modulators for 400/600Gbps applications, electrostatic chucks for next-generation semiconductor equipment, cosmetic materials and cathode materials for automotive secondary batteries.
  17. FY2021-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,337 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company disclosed R&D expenses of ¥2,337 million and reconfirmed that there were no significant changes in its R&D activities.
  18. FY2021-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,618 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The Company reconfirmed that there were no significant changes in its R&D activities and disclosed R&D expenses of ¥1,618 million for the cumulative second quarter.
  19. FY2021-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥827 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company disclosed R&D expenses of ¥827 million and reconfirmed that there were no significant changes in its R&D activities.
  20. FY2020AdvancedAnnual report

    「① Commercialization of coherent LN modulators for common use in 100G/200G transmission systems ② Development of coherent LN modulators adapted to next-generation 400G/600G transmission systems ③ Development of foundational technologies for next-generation compact optical devices」

    The Company reported specific R&D results in the optoelectronics field, including commercialization of products for 100G/200G applications, development of products for 400G/600G applications and development of foundational technologies for next-generation devices. Full-year R&D expenses were ¥3,087 million.
  21. FY2020-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,287 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company disclosed R&D expenses of ¥2,287 million and stated that there were no significant changes in its R&D activities.
  22. FY2020-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,488 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed R&D expenses of ¥1,488 million for the cumulative second quarter.
  23. FY2020-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥726 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed quarterly R&D expenses of ¥726 million.
  24. FY2019-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,433 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed cumulative R&D expenses of ¥2,433 million.
  25. FY2019-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,560 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed first-half R&D expenses of ¥1,560 million.
  26. FY2019-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥791 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed quarterly R&D expenses of ¥791 million.
  27. FY2018-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,171 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed cumulative R&D expenses of ¥2,171 million.
  28. FY2018-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥739 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company disclosed R&D expenses of ¥739 million and stated that there were no significant changes in its R&D activities.
  29. FY2017RestatedAnnual report

    「The Group, comprising the Company and its consolidated subsidiaries, conducts broad and proactive R&D based on its basic philosophy of continuously developing proprietary technologies, ranging from research into new technologies and products related to its core cement and concrete businesses and surrounding fields such as construction materials, to R&D in the optoelectronics, new materials and battery materials businesses, which are new businesses based on those foundational technologies. R&D expenses for the fiscal year were ¥2,969 million.」

    The Company reconfirmed its policy of conducting broad R&D into its existing businesses and optoelectronics, new materials and battery materials based on proprietary technologies, and disclosed full-year R&D expenses.
  30. FY2017-Q3RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative third quarter was ¥2,201 million. There were no significant changes in the status of the Group's R&D activities during the cumulative third quarter.」

    The Company disclosed R&D expenses of ¥2,201 million and stated that there were no significant changes in its R&D activities.
  31. FY2017-Q2RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative second quarter was ¥1,495 million. There were no significant changes in the status of the Group's R&D activities during the cumulative second quarter.」

    The Company stated that there were no significant changes in its R&D activities and disclosed first-half R&D expenses of ¥1,495 million.
  32. FY2017-Q1RestatedAnnual report

    「The amount spent on R&D activities by the Group as a whole during the cumulative first quarter was ¥778 million. There were no significant changes in the status of the Group's R&D activities during the cumulative first quarter.」

    The Company disclosed quarterly R&D expenses of ¥778 million and stated that there were no significant changes in its R&D activities.
  33. FY2016First statedAnnual report

    「The Company continuously conducts broad and proactive R&D based on its basic philosophy of developing proprietary technologies, ranging from research into new technologies and products related to its core cement and concrete businesses and surrounding fields such as construction materials, to R&D in the optoelectronics, new materials and battery materials businesses, which are new businesses based on those foundational technologies.」

    The R&D staff numbers approximately 200, and R&D expenses for the fiscal year were ¥3,060 million. Research covers optical modulators for 100G and 200/400G applications, next-generation semiconductor materials and secondary battery cathode materials.
Moved together

"Investments to Rationalize Production and Logistics and Investments in Growth Areas" moved the same way as this thread, in the same document, in 6 of its 33 moves.

655544★123456
  1. ★This thread
  2. 1Investments to Rationalize Production and Logistics and Investments in Growth Areas6×
  3. 2Capital policy through share repurchases5×
  4. 3Expansion of Waste Treatment and Environmental Businesses5×
  5. 4Review of CO2 Emissions Reduction Targets and Specific Measures5×
  6. 5Reduction of Interest-Bearing Debt4×
  7. 6Surging raw material and fuel prices4×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Sumitomo Osaka Cement yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Strengthening research and development based on proprietary technologies | Sumitomo Osaka Cement Co.,Ltd. (5232) | Komori